Swedish Orphan Biovitrum AB

SOBI: XSTO (SWE)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
>?%LOCK|k!p^tLOCK|Q#Y@gF

Sobi Earnings: Strategic Portfolio Strength and Altuvoct Uptake Offset Beyfortus Royalty Declines

Sobi reported first-quarter revenue of SEK 7.18 billion, rising 24% year over year at constant exchange rates. Hematology revenue increased 24%, largely driven by sales of Altuvoct and Doptelet, which grew 186% and 44% from the prior year, respectively.

Sponsor Center